Protective effect of lutein against acrolein-induced ototoxicity in rats

ArticleAçık Erişim

Özet

Background: Acrolein is a reactive aldehyde that forms during burning of wood and other fuels. It is also a product of lipid peroxidation (LPO) reactions and is present in cigarette smoke. Acrolein is known to cause oxidative stress and inflammatory nerve tissue damage. Lutein is a tetraterpenoid molecule with antioxidant and anti-inflammatory properties. There appear to be no studies on the effect of lutein on vestibulocochlear nerve damage induced by acrolein. The aim of this study was to investigate the effect of lutein on vestibulocochlear nerve damage induced by acrolein in rats using biochemical and histopathological methods. Methods: The rats were divided into three groups (n = 6, for each group) a healthy control group (HG), an acrolein (ACR) group and a lutein and acrolein (LACR) group. In the LACR group, lutein was administered (1 mg/kg) via oral gavage. The ACR and HG groups received saline via oral gavage. Then, 1 h after the administration of lutein and saline, the LACR and ACR groups were treated with 3 mg/kg of acrolein via oral gavage. This procedure was repeated once a day for 30 days. Results: The results of biochemical experiments showed that in the vestibulocochlear nerve tissues of the animals treated with acrolein, the levels of malondialdehyde, total oxidants, nuclear factor kappa b, tumor necrosis factor alpha and interleukin 1 beta significantly increased, whereas the levels of total glutathione and total antioxidants decreased as compared to those in the HG and LACR groups. In addition, severe histopathological damage was observed in vestibulocochlear nerve tissue of the acrolein group, whereas this damage was alleviated in the lutein group. Conclusion: Lutein protected vestibulocochlear nerve tissue from acrolein-associated oxidative and proinflammatory damage. This suggests that lutein might be useful in preventing or treating acrolein-induced ototoxicity. © 2021

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13299Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorErhan, Ertugrul
dc.contributor.authorSalcan, Ismail
dc.contributor.authorBayram, Rana
dc.contributor.authorSuleyman, Bahadir
dc.contributor.authorDilber, Muhammet
dc.contributor.authorYazici, Gulce Naz
dc.contributor.authorCoban, Taha Abdulkadir
dc.contributor.authorAltuner, Durdu
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:28:08.288721562Z
dc.date.available2026-10-18T20:28:08.288721562Z
dc.date.issued2021
dc.description.abstractBackground: Acrolein is a reactive aldehyde that forms during burning of wood and other fuels. It is also a product of lipid peroxidation (LPO) reactions and is present in cigarette smoke. Acrolein is known to cause oxidative stress and inflammatory nerve tissue damage. Lutein is a tetraterpenoid molecule with antioxidant and anti-inflammatory properties. There appear to be no studies on the effect of lutein on vestibulocochlear nerve damage induced by acrolein. The aim of this study was to investigate the effect of lutein on vestibulocochlear nerve damage induced by acrolein in rats using biochemical and histopathological methods. Methods: The rats were divided into three groups (n = 6, for each group) a healthy control group (HG), an acrolein (ACR) group and a lutein and acrolein (LACR) group. In the LACR group, lutein was administered (1 mg/kg) via oral gavage. The ACR and HG groups received saline via oral gavage. Then, 1 h after the administration of lutein and saline, the LACR and ACR groups were treated with 3 mg/kg of acrolein via oral gavage. This procedure was repeated once a day for 30 days. Results: The results of biochemical experiments showed that in the vestibulocochlear nerve tissues of the animals treated with acrolein, the levels of malondialdehyde, total oxidants, nuclear factor kappa b, tumor necrosis factor alpha and interleukin 1 beta significantly increased, whereas the levels of total glutathione and total antioxidants decreased as compared to those in the HG and LACR groups. In addition, severe histopathological damage was observed in vestibulocochlear nerve tissue of the acrolein group, whereas this damage was alleviated in the lutein group. Conclusion: Lutein protected vestibulocochlear nerve tissue from acrolein-associated oxidative and proinflammatory damage. This suggests that lutein might be useful in preventing or treating acrolein-induced ototoxicity. © 2021
dc.description.sponsorshipWe would like to thank the Ataturk University Medical Experimental Application and Research Center.
dc.identifier.doi10.1016/j.biopha.2021.111281
dc.identifier.eissn1950-6007
dc.identifier.issn0753-3322
dc.identifier.pmid33578233
dc.identifier.scopus2-s2.0-85100694400
dc.identifier.startpage111281
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13299
dc.identifier.volume137
dc.identifier.wosWOS:000634752900001
dc.language.isoen
dc.publisherElsevier Masson s.r.l.
dc.relation.ispartofBiomedicine and Pharmacotherapy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcrolein
dc.subjectLutein
dc.subjectOtotoxicity
dc.subjectRat
dc.subjectAnimals
dc.subjectAnti-Inflammatory Agents
dc.subjectAntioxidants
dc.subjectDisease Models, Animal
dc.subjectInflammation Mediators
dc.subjectMale
dc.subjectOxidative Stress
dc.subjectRats, Wistar
dc.subjectVestibulocochlear Nerve
dc.subjectVestibulocochlear Nerve Diseases
dc.subjectantioxidant
dc.subjectglutathione
dc.subjectimmunoglobulin enhancer binding protein
dc.subjectinterleukin 1beta
dc.subjectmalonaldehyde
dc.subjectsodium chloride
dc.subjecttumor necrosis factor
dc.subjectxanthophyll
dc.subjectantiinflammatory agent
dc.subjectautacoid
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectantioxidant activity
dc.subjectArticle
dc.subjectbiochemical analysis
dc.titleProtective effect of lutein against acrolein-induced ototoxicity in rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus19
rdl.citation.wos15
rdl.departmentDepartment of Otorhinolaryngology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Histology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Medical Biochemistry, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. Electronic address: halis.suleyman@gmail.com.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)